Related Experiment Video
Updated: Dec 30, 2025

09:59
Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
Published on: March 31, 2023
1.3K
STA-55, an Easily Accessible, Broad-Spectrum, Activity-Based Aldehyde Dehydrogenase Probe
Sebastiaan T A Koenders1, Eva J van Rooden1, Hans van den Elst2
1Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Chembiochem : a European Journal of Chemical Biology
|January 28, 2020
Summary
Aldehyde dehydrogenases (ALDHs) are upregulated in cancer and linked to therapy resistance. A new probe helps profile ALDH inhibitors, aiding the development of targeted cancer therapies.
Area of Science:
- Biochemistry
- Enzymology
- Cancer Biology
Background:
- Aldehyde dehydrogenases (ALDHs) are enzymes crucial for aldehyde metabolism.
- ALDHs are frequently upregulated in various cancers.
- Their role in cancer progression and therapy resistance highlights their potential as therapeutic targets.
Purpose of the Study:
- To develop and utilize a novel activity-based probe (ABP) for broad-spectrum ALDH profiling.
- To assess the selectivity of existing ALDH inhibitors using competitive activity-based protein profiling (ABPP).
- To validate target engagement of ALDH inhibitors in a relevant cancer model.
Main Methods:
- Synthesis of a broad-spectrum activity-based probe for ALDHs.
- Application of competitive ABPP using the developed probe.
- Analysis of ALDH inhibitor selectivity profiles in lung cancer cells.
Main Results:
- A novel ABP capable of reporting on multiple ALDH enzymes was successfully developed.
- Competitive ABPP revealed distinct selectivity profiles for three tested ALDH inhibitors.
- The study established target engagement for these inhibitors in lung cancer cells.
Conclusions:
- The developed ABP is a valuable tool for evaluating ALDH inhibitors.
- Understanding inhibitor selectivity is critical for developing effective cancer therapies targeting ALDHs.
- This approach facilitates the discovery and validation of new ALDH-targeted drugs.

